Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib

Singh, AP; Umbarkar, P; Tousif, S; Lal, H

Singh, AP; Lal, H (corresponding author), Univ Alabama Birmingham, UAB, Div Cardiovasc Dis, 1720 2nd Ave South, Birmingham, AL 35294 USA.

INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020; 316 (): 214

Abstract

The advent of tyrosine kinase inhibitors (TKIs) targeted therapy revolutionized the treatment of chronic myeloid leukemia (CML) patients. However, car......

Download PDF


Full Text Link


打开APP